Clinuvel Continues Share Buy-Back Campaign
Company Announcements

Clinuvel Continues Share Buy-Back Campaign

Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.

Clinuvel Pharmaceuticals Limited has announced an ongoing buy-back of its shares, with the latest update indicating that the company purchased 3,800 shares on the previous day, adding to a total of 61,190 shares bought back to date. This buy-back is part of their market strategy to reacquire ordinary fully paid shares, under the ASX code CUV, as detailed in their latest daily notification.

For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskClinuvel Pharmaceuticals Announces Director Change and Shareholdings
TipRanks Australian Auto-Generated NewsdeskClinuvel Pharmaceuticals Reports Key AGM Resolutions
TipRanks Australian Auto-Generated NewsdeskClinuvel Pharmaceuticals Faces Challenges Amid Market Dynamics
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App